Cardiovascular Improvements With MV ASV Therapy in Heart Failure
A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 126 participants.
Also called NCT01953874
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose supportive care
- Phase
- Not applicable
- Enrolled
- 126 participants
- Sponsor
- Registry
-
NCT01953874
-
- Other papers using this trial's data
- Adaptive servo-ventilation reduces atrial fibrillation burden in patients with heart failure and sleep apnea
- Cardiovascular Outcomes With Minute Ventilation-Targeted Adaptive Servo-Ventilation Therapy in Heart Failure: The CAT-HF Trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Germany
- Registry status
- Terminated
Technical summary
Registry record NCT01953874. Randomized; no masking; primary purpose supportive care. Start 2013-12 (registry gives no type); primary completion 2015-12 (actual). Results posted on 2018-02-28.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Cardiovascular Improvements With MV ASV Therapy in Heart Failure
- Acronym
- CAT-HF
- Condition
- Acute Decompensated Heart Failure
- Condition
- Sleep Disordered Breathing
- Intervention (Device)
- MV ASV
- Intervention (Drug)
- Optimized Medical Treatment
- Lead sponsor
- ResMed
- Collaborator
- ResMed Foundation
Record details
- Record id
cardio:ct-nct01953874- Content hash
4502d0361a6006976085f01fdd0b184919fe9a1efb060c9bc993c30db9e2844e